FBIO
Fortress Biotech, Inc.
There isn't enough reported data to score FBIO yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
FBIO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Unavailable | |
| Unavailable |
FBIO's revenue is currently healthy, and its profitability is stable. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
FBIO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.7x | $2.01 | +0.8% |
| Current | 0.7x | $1.99 | — |
| Fair | 0.9x | $2.32 | +17% |
| Expensive | 1x | $2.77 | +39% |
Historical ranges are pointers, not guarantees.
FBIO has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
FBIO Forward outlook
There aren't enough analyst estimates for FBIO to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
FBIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.70 | +$3.66 |
| Q1 2026 | $3.23 | +$5.37 |
| Q4 2025 | -$0.07 | +$2.62 |
| Q3 2023 | -$12.19 | +$3.56 |
| Q2 2023 | -$15.00 | +$0.90 |
| Q1 2023 | -$15.00 | -$2.10 |
| Q4 2022 | -$14.55 | -$2.70 |
| Q3 2022 | -$15.75 | -$8.55 |
FBIO has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
FBIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.7M | +14% |
| Q1 2026 | $16M | +22% |
| Q4 2025 | $16.1M | +6.3% |
| Q3 2025 | $17.6M | +21% |
| Q2 2025 | $16.4M | +10% |
| Q1 2025 | $13.1M | +0.8% |
| Q4 2024 | $15.1M | -24% |
| Q3 2024 | $14.6M | -58% |
FBIO's revenue is recovering but still below its 2023 peak: $19M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -53% | +169 points |
| Q1 2026 | -48% | +122 points |
| Q4 2025 | -30% | +128 points |
| Q3 2025 | -39% | +112 points |
| Q2 2025 | -222% | -36 points |
| Q1 2025 | -170% | +111 points |
| Q4 2024 | -158% | -59 points |
| Q3 2024 | -151% | -111 points |
FBIO's operating margin was −53% last quarter, up 169 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over FBIO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over FBIO on profitability, with a higher operating margin.
FBIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $203.9M | +$223.4M |
| Q4 2025 | -$12.5M | +$363K |
| Q3 2025 | -$6.1M | +$13.9M |
| Q1 2025 | -$19.6M | +$5.8M |
| Q4 2024 | -$12.9M | +$22.1M |
| Q3 2024 | -$20.1M | -$3.3M |
| Q1 2024 | -$25.4M | +$17.8M |
| Q4 2023 | -$35M | +$13M |
FBIO has the stronger cash trend. Its trailing FCF is up 243% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
FBIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -17% | -6.6M shares |
| 1 year | +6.6% | +2M shares |
| 3 years | +437% | +25.9M shares |
| 5 years | +527% | +26.7M shares |
FBIO has 32M diluted shares, up 6.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over FBIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
FBIO Net Leverage
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
FBIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.7 | Neutral |
| Stochastic | 8.6 | Oversold |
FBIO's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
FBIO PE vs Healthcare Sector
| Metric | FBIO | Sector median | Relative |
|---|---|---|---|
| PE | 0.7x | 26x | 97% below |
| PE % | 15 | 29 | 14 pts below |
FBIO has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
FBIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.00 | 0.5% below |
| 20 week MA | $2.56 | 22% below |
| 50 week MA | $2.84 | 30% below |
| 100 week MA | $2.49 | 20% below |
| 200 week MA | $3.62 | 45% below |
FBIO is in a downtrend: it's below all five of its weekly moving averages, and 45% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over FBIO on trend strength, trading above more of its moving averages.
FBIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.1 | $51.5 | +39% |
| 2021 | $51.5 | $39.3 | -24% |
| 2022 | $39.3 | $8.25 | -79% |
| 2023 | $8.25 | $3.01 | -64% |
| 2024 | $3.01 | $2.36 | -22% |
| 2025 | $2.36 | $3.74 | +58% |
| 2026 YTD | $3.74 | $1.99 | -47% |
FBIO has finished lower in four of the last six years. It's down 47% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over FBIO on returns for 2026, with the stronger performance.